Ann: Emyria receives $1,162,000 R&D Tax Incentive Refund, page-6

  1. 37 Posts.
    lightbulb Created with Sketch. 23
    more massive news on the horizon when results from the second MAPS phase 3 MDMA for PTSD trial are announced - likely early-mid 2022 if positive results.

    that’ll be two positive phase 3s - all the FDA needs for approval...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.8¢
Change
0.002(4.35%)
Mkt cap ! $28.12M
Open High Low Value Volume
4.7¢ 4.8¢ 4.6¢ $94.23K 1.998M

Buyers (Bids)

No. Vol. Price($)
1 89338 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 473905 6
View Market Depth
Last trade - 11.19am 31/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.